Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.
Note: Council approval does not guarantee that a concept will become an initiative.
Table of Contents
Fiscal Year (FY) 2025 Concepts
- Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Genomics in Immune-Mediated Diseases
- Immunobiology of Xenotransplantation Cooperative Research Program
- Novel Approaches for Radiation Biodosimetry and Medical Countermeasures Development
FY 2025 Small Business Innovation Research (SBIR) Contract Solicitation Topics
- Adjuvant Development for Vaccines and for Autoimmune and Allergic Diseases
- Adjuvant Discovery and Down-Selection for Vaccines Against Infectious and Immune-Mediated Diseases
- Reagents for Immunologic Analysis of Non-Mammalian and Underrepresented Mammalian Models
Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Genomics in Immune-Mediated Diseases
For the published request for applications, check the April 23, 2024 Guide announcement, Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Genomics in Immune-Mediated Diseases (U01, Clinical Trial Not Allowed).
Immunobiology of Xenotransplantation Cooperative Research Program
For the published requests for applications, check the April 1, 2024 Guide announcements, Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed) and Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed).
Novel Approaches for Radiation Biodosimetry and Medical Countermeasures Development
For the published request for applications, check the July 30, 2024 Guide announcement, Novel Approaches for Radiation Biodosimetry and Medical Countermeasure Development (R21, Clinical Trial Not Allowed).
Adjuvant Development for Vaccines and for Autoimmune and Allergic Diseases
For the published request for proposals, check the August 2, 2024 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.
Adjuvant Discovery and Down-Selection for Vaccines Against Infectious and Immune-Mediated Diseases
For the published request for proposals, check the August 2, 2024 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.
Reagents for Immunologic Analysis of Non-Mammalian and Underrepresented Mammalian Models
For the published request for proposals, check the August 2, 2024 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.